CMS grants New Technology Add-On Payment for ZEVASKYN, creating new billing pathway

CMS granted New Technology Add-On Payment status to ZEVASKYN. The NTAP designation provides additional Medicare reimbursement for qualifying cases using this new technology, typically for two to three years, to bridge the gap until the technology is incorporated into the standard DRG payment. This creates a new, temporary billing pathway for hospitals and providers using this specific product. Billing and clinical teams in relevant specialties should confirm the specific ICD-10 and CPT codes required to trigger the NTAP payment with their Medicare Administrative Contractor. Monitor the Inpatient Only List and OPPS updates to see if the technology receives permanent payment classification.